Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone

References

• de Leon J, Diaz FJ. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res, 76:135–157.
   PubMed Web of Science ®Google Scholar
• Shore D. (1998). Recent developments in atypical antipsychotic medications. Schizophr Bull, 24:33.
   PubMed Web of Science ®Google Scholar
• Branford D. (2003). Schizophrenia. In: Walker R, Edwards C eds Clinical Pharmacy and Therapeutics. 3rd ed. London: Churchill Livingstone, 459–460.
   Google Scholar
• Newcomer JW. (2005). Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs, 19 Suppl 1:1–93.
   PubMed Web of Science ®Google Scholar
• Aggarwal G, Dhawan S. (2009). Development, fabrication and evaluation of transdermal drug delivery system-A review. Latest Reviews [Online], 7(5). Available at www.pharmainfo.net. Assessed on 30 July 2011.
   Google Scholar
• Nedberg DE, Gale RM, Crisologo NM, Wen J, Imbert EC, Luciano A, Silverberg EN, Foreman PB. (2007, March). Transdermal risperidone delivery system. WO/2007/035942.
   Google Scholar
• Wertheimer AI, Santella TM, Finestone AJ, Levy RA. (2005). Drug delivery systems improve pharmaceutical profile and facilitate medication adherence. Adv Ther, 22:559–577.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Kaur MP. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm, 26:1131–1140.
   PubMed Web of Science ®Google Scholar
• Charoo NA, Shamsher AA, Kohli K, Pillai K, Rahman Z. (2008). Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil. Colloids Surf B Biointerfaces, 65:300–307.
   PubMed Web of Science ®Google Scholar
• Jain R, Aqil M, Ahad A, Ali A, Khar RK. (2008). Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride. Drug Dev Ind Pharm, 34:384–389.
   PubMed Web of Science ®Google Scholar
• Sharma S, Aggarwal G, Dhawan S. (2010). Design and evaluation of olanzapine transdermal patches containing vegetable oils as permeation enhancers. Der Pharmacia Lettre, 2(6):84–98.
   Google Scholar
• Chandak AR, Verma PRP. (2010). Eudragit based transdermal delivery system of Pentazocin: Phycochemical, in vitro and in vivo evaluations. Pharm Dev Technol, 15:296–304.
   PubMed Web of Science ®Google Scholar
• Jayaprakash S, Halith SM, Firthouse PM, Yasmin, Nagarajan M. (2010). Preparation and evaluation of celecoxib transdermal patches. Pak J Pharm Sci, 23:279–283.
   PubMed Web of Science ®Google Scholar
• Yener G, Üner M, Gönüllü Ü, Yildirim S, Kiliç P, Aslan SS et al. (2010). Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies. Chem Pharm Bull, 58:1466–1473.
   PubMed Web of Science ®Google Scholar
• Mittal A, Parmar S, Singh B. (2009). In vitro and in vivo assessment of matrix type transdermal therapeutic system of labetalol hydrochloride. Curr Drug Deliv, 6:511–519.
   PubMedGoogle Scholar
• El-Massik MA, Darwish IA, Hassan EE, El-Khordagui LK. (1996). Development of a dissolution medium for glibenclamide. Int J Pharm, 140:69–76.
   Web of Science ®Google Scholar
• Setty CM, Jawarkar Y, Pathan IB. (2010). Effect of essential oils as permeation enhancers on percutaneous penetration of furosemide through human cadaver skin. Acta Pharmaceut Sciencia, 52:159–168.
   Google Scholar
• Chandak AR, Verma PR. (2008). [Design and development of hydroxypropyl methycellulose (HPMC) based polymeric films of methotrexate: physicochemical and pharmacokinetic evaluations]. Yakugaku Zasshi, 128:1057–1066.
   PubMed Web of Science ®Google Scholar
• Zhang G, Terry AV Jr, Bartlett MG. (2007). Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci, 856:20–28.
   PubMed Web of Science ®Google Scholar
• Samanta MK, Dube R, Suresh B. (2003). Transdermal drug delivery system of haloperidol to overcome self-induced extrapyramidal syndrome. Drug Dev Ind Pharm, 29:405–415.
   PubMed Web of Science ®Google Scholar
• Hai NT, Kim J, Park ES, Chi SC. (2008). Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine. Int J Pharm, 357:55–60.
   PubMed Web of Science ®Google Scholar
• Avenoso A, Facciolà G, Salemi M, Spina E. (2000). Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl, 746:173–181.
   PubMed Web of Science ®Google Scholar
• Chandra A, Sharma PK. (2009). Transdermal delivery of Ketorolac. Yakugaku Zasshi, 129(3):373–379.
   PubMed Web of Science ®Google Scholar
• Verma PR, Iyer SS. (2000). Transdermal delivery of propranolol using mixed grades of Eudragit: design and in vitro and in vivo evaluation. Drug Dev Ind Pharm, 26:471–476.
   PubMed Web of Science ®Google Scholar
• Ubaidulla U, Reddy MV, Ruckmani K, Ahmad FJ, Khar RK. (2007). Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech, 8:2.
   PubMed Web of Science ®Google Scholar
• Gullick DR, Pugh WJ, Ingram MJ, Cox PA, Moss GP. (2010). Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption. Drug Dev Ind Pharm, 36:926–932.
   PubMed Web of Science ®Google Scholar
• Shamsher AA, Charoo NA, Kohli K, Pillai K, Rahman Z. (2010). Effect of transdermally delivered aspirin on blood coagulation parameters. Am J Biomed Sci, 2:129–141.
   Google Scholar
• Aggarwal G, Dhawan S, Harikumar SL. (2011, Sep 14). Formulation, in vitro and in vivo evaluation of matrix type transdermal patches of Olanzapine. Pharm Dev Technol. [Epub ahead of print] DOI: 10.3109/10837450. 2011.609993
   PubMed Web of Science ®Google Scholar
• Karande P, Mitragotri S. (2009). Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta, 1788:2362–2373.
   PubMed Web of Science ®Google Scholar
• Li L, Fang L, Xu X, Liu Y, Sun Y, He Z. (2010). Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole. Biopharm Drug Dispos, 31:138–149.
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Kanupriya Mahapatra, S, Das S, Patra B. (2005). Sorbitan monolaurate 20 as a potential skin permeation enhancer in transdermal patches. J Applied Research, 5:96–107.
   Google Scholar
• Escobar-Chávez JJ, Merino V, Díez-Sales O, Nácher-Alonso A, Ganem-Quintanar A, Herráez M et al. (2011). Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation. Pharm Dev Technol, 16:162–169.
   PubMed Web of Science ®Google Scholar
• Charoo NA, Anwer A, Kohli K, Pillai KK, Rahman Z. (2005). Transdermal delivery of flurbiprofen: permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino rats. Pharm Dev Technol, 10:343–351.
   PubMed Web of Science ®Google Scholar
• Aggarwal G, Garg A, Dhawan S. (2009). Transdermal drug delivery: Evolving technologies and expanding opportunities. Ind J Pharm Educ Res, 43(3):251–259.
   Web of Science ®Google Scholar
• Alam MI, Baboota S, Kohli K, Ali J, Ahuja A. (2009). Development and evaluation of transdermal patches of celecoxib. PDA J Pharm Sci Technol, 63:429–437.
   PubMedGoogle Scholar
• Sanap GS, Dama GY, Hande AS, Karpe SP, Nalawade SV, Kakade RS, Jadhav UY. (2008). Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer. Int J Green Pharmacy, 2:129–133.
   Google Scholar
• Jamieson GS, Baughman WF, Brauns DH. (1921). The chemical composition of peanut oil. J Am Chem Soc, 43:1372–1381.
   Google Scholar
• Wang LH, Wang CC, Kuo SC. (2007). Vehicle and enhancer effects on human skin penetration of aminophylline from cream formulations: evaluation in vivo. J Cosmet Sci, 58:245–254.
   PubMed Web of Science ®Google Scholar
• De P, Damodharan N, Mallick S, Mukherjee B. (2009). Development and evaluation of nefopam transdermal matrix patch system in human volunteers. PDA J Pharm Sci Technol, 63:537–546.
   PubMedGoogle Scholar
• Ren C, Fang L, Ling L, Wang Q, Liu S, Zhao L et al. (2009). Design and in vivo evaluation of an indapamide transdermal patch. Int J Pharm, 370:129–135.
   PubMed Web of Science ®Google Scholar